Efficacy of some non-conventional herbal medications (sulforaphane, tanshinone iia, and tetramethylpyrazine) in inducing neuroprotection in comparison with interleukin-10 after spinal cord injury: A meta-analysis

Journal of Spinal Cord Medicine

Volumn 38, Issue 1, 2015, Pages 13-22

  Koushki, Davood ^a   Latifi, Sahar ^b   Javidan, Abbas Norouzi ^b   Matin, Marzieh ^b  

^a IRAN UNIVERSITY OF MEDICAL SCIENCES   (Iran)

^b TEHRAN UNIVERSITY OF MEDICAL SCIENCES   (Iran)

Author keywords

Cytokines; Neuroinflammation; Pharmacology; Spinal cord

Indexed keywords

INTERLEUKIN 10; SULFORAPHANE; TANSHINONE IIA; TETRAMETHYLPYRAZINE; ABIETANE DERIVATIVE; ISOTHIOCYANIC ACID DERIVATIVE; NEUROPROTECTIVE AGENT; PYRAZINE DERIVATIVE; SULFORAFAN; TANSHINONE;

CONFERENCE PAPER; DRUG EFFICACY; DRUG MECHANISM; NERVOUS SYSTEM INFLAMMATION; NEUROPROTECTION; NONHUMAN; SPINAL CORD INJURY; SYSTEMATIC REVIEW; COMPARATIVE STUDY; HERBAL MEDICINE; HUMAN; META ANALYSIS; PROCEDURES; SPINAL CORD INJURIES;

DITERPENES, ABIETANE; HERBAL MEDICINE; HUMANS; INTERLEUKIN-10; ISOTHIOCYANATES; NEUROPROTECTIVE AGENTS; PYRAZINES; SPINAL CORD INJURIES;

EID: 84921033329     PISSN: 10790268     EISSN: 20457723     Source Type: Journal    
DOI: 10.1179/2045772314Y.0000000215     Document Type: Conference Paper

References (73)

1. Trivedi A, Olivas AD, Noble-Haeusslein LJ. Inflammation and spinal cord injury: infiltrating leukocytes as determinants of injury and repair processes. Clin Neurosci Res 2006;6(5):283-92.
2. Donnelly DJ, Popovich PG. Inflammation and its role in neuroprotection, axonal regeneration and functional recovery after spinal cord injury. Exp Neurol 2008;209(2):378-88.
3. Kwon BK, Tetzlaff W, Grauer JN, Beiner J, Vaccaro AR. Pathophysiology and pharmacologic treatment of acute spinal cord injury. Spine J 2004;4(4):451-64.
4. Young W. Secondary injury mechanisms in acute spinal cord injury. J Emerg Med 1993;11(Suppl 1):13-22.
5. Taoka Y, Okajima K. Role of leukocytes in spinal cord injury in rats. J Neurotrauma 2000;17(3):219-29.
6. Tator CH, Hashimoto R, Raich A, Norvell D, Fehlings MG, Harrop JS, et al. Translational potential of preclinical trials of neuroprotection through pharmacotherapy for spinal cord injury. J Neurosurg Spine 2012;17(1 Suppl):157-229.
7. Akira S, Hirano T, Taga T, Kishimoto T. Biology of multifunctional cytokines: IL 6 and related molecules (IL 1 and TNF). FASEB J 1990;4(11):2860-7.
8. Genovese T, Esposito E, Mazzon E, Di Paola R, Caminiti R, Bramanti P, et al. Absence of endogenous interleukin-10 enhances secondary inflammatory process after spinal cord compression injury in mice. J Neurochem 2009;108(6):1360-72.
9. Howard M, O'Garra A, Ishida H, de Waal Malefyt R, de Vries J. Biological properties of interleukin 10. J Clin Immunol 1992;12(4): 239-47.
10. Kwon BK, Okon E, Hillyer J, Mann C, Baptiste D, Weaver LC, et al. A systematic review of non-invasive pharmacologic neuroprotective treatments for acute spinal cord injury. J Neurotrauma 2011;28(8):1545-88.
11. Higgins JP, Thompson SG, Deeks JJ, Altman DG. Measuring inconsistency in meta-analyses. BMJ 2003;327:557-60.
12. Kontopantelis E, Springate DA, Reeves D. A re-analysis of the Cochrane Library data: The dangers of unobserved heterogeneity in meta-analyses. PLoS One 2013;8(7):e69930.
13. Milligan ED, Soderquist RG, Malone SM, Mahoney JH, Hughes TS, Langer SJ, et al. Intrathecal polymer-based interleukin-10 gene delivery for neuropathic pain. Neuron Glia Biol 2006;2(4):293-308.
14. Milligan ED, Langer SJ, Sloane EM, He L, Wieseler-Frank J, O'Connor K, et al. Controlling pathological pain by adenovirally driven spinal production of the anti-inflammatory cytokine, interleukin- 10. Eur J Neurosci 2005;21(8):2136-48.
15. Milligan ED, Sloane EM, Langer SJ, Hughes TS, Jekich BM, Frank MG, et al., Repeated intrathecal injections of plasmid DNA encoding interleukin-10 produce prolonged reversal of neuropathic pain. Pain 2006;126(1-3):294-308.
16. Zhou Z, Peng X, Insolera R, Fink DJ, Mata M. IL-10 promotes neuronal survival following spinal cord injury. Exp Neurol 2009; 220(1):183-90.
17. Basso DM, Beattie MS, Bresnahan JC. A sensitive and reliable locomotor rating scale for open field testing in rats. J Neurotrauma 1995;12(1):1-21.
18. Oruckaptan HH, Ozisik P, Atilla P, Tuncel M, Kilinc K, Geyik PO, et al. Systemic administration of interleukin-10 attenuates early ischemic response following spinal cord ischemia reperfusion injury in rats. J Surg Res 2009;155(2):345-56.
19. Kanellopoulos GK, Kato H, Hsu CY, Kouchoukos NT. Spinal cord ischemic injury: development of a new model in the rat. Stroke 1997;28(12):2532.
20. Jackson CA, Messinger J, Peduzzi JD, Ansardi DC, Morrow CD. Enhanced functional recovery from spinal cord injury following intrathecal or intramuscular administration of poliovirus replicons encoding IL-10. Virology 2005;336(2):173-83.
21. Brewer KL, Bethea JR, Yezierski RP. Neuroprotective effects of interleukin-10 following excitotoxic spinal cord injury. Exp Neurol 1999;159(2):484-93.
22. Pearse DD, Marcillo AE, Oudega M, Lynch MP, Wood PM, Bunge MB. Transplantation of Schwann cells and olfactory ensheathing glia after spinal cord injury: does pretreatment with methylprednisolone and interleukin-10 enhance recovery? J Neurotrauma 2004;21(9):1223-39.
23. Takami T, Oudega M, Bethea JR, Wood PM, Kleitman N, Bunge MB. Methylprednisolone and interleukin-10 reduce gray matter damage in the contused Fischer rat thoracic spinal cord but do not improve functional outcome. J Neurotrauma 2002;19(5): 653-66.
24. Bethea JR, Nagashima H, Acosta MC, Briceno C, Gomez F, Marcillo AE, et al. Systemically administered interleukin-10 reduces tumor necrosis factor-alpha production and significantly improves functional recovery following traumatic spinal cord injury in rats. J Neurotrauma 1999;16:851-63.
25. Mao L, Wang HD, Wang XL, Qiao L, Yin HX. Sulforaphane attenuates matrix metalloproteinase-9 expression following spinal cord injury in mice. Ann Clin Lab Sci 2010;40(4):354-60.
26. Miller DM, Singh IN, Wang JA, Hall ED. Administration of the Nrf2-ARE activators sulforaphane and carnosic acid attenuates 4-hydroxy-2-nonenal-induced mitochondrial dysfunction ex vivo. Free Radic Biol Med 2013;57(10):1-9.
27. Mao L, Wang H, Wang X, Liao H, Zhao X. Transcription factor Nrf2 protects the spinal cord from inflammation produced by spinal cord injury. J Surg Res 2011;170(1):e105-15.
28. Basso DM, Fisher LC, Anderson AJ, Jakeman LB, McTigue DM, Popovich PG. Basso Mouse Scale for locomotion detects differences in recovery after spinal cord injury in five common mouse strains. J Neurotrauma 2006;23(5):635-59.
29. Yin X, Yin Y, Cao FL, Chen YF, Peng Y, Hou WG, et al. Tanshinone IIA attenuates the inflammatory response and apoptosis after traumatic injury of the spinal cord in adult rats. PLoS One 2012;7(6):e38381.
30. Zhang L, An GY, Zhang WG, Chen K. Effects of tanshinone-II A sulfonate on expression of nuclear factor-kappaB, vascular cell adhesion molecule-1 and hemorrheology during spinal cord ischemia reperfusion injury. Zhongguo Gu Shang 2012;25(12):1016-20.
31. Fan L, Wang K, Shi Z, Die J, Wang C, Dang X. Tetramethylpyrazine protects spinal cord and reduces inflammation in a rat model of spinal cord ischemia-reperfusion injury. J Vasc Surg 2011;54(1):192-200.
32. Liang Y, Yang QH, Yu XD, Jiang DM. Additive effect of tetramethylpyrazine and deferoxamine in the treatment of spinal cord injury caused by aortic cross-clamping in rats. Spinal Cord 2011; 49(2):302-6.
33. Zea-longa E, Weinstein PR, Carlson S. Reversible middle cerebral artery occlusion without craniectomy in rat. Stroke 1989;20(1): 84-91.
34. Fan LH, Wang KZ, Cheng B, Wang CS, Dang XQ. Anti-apoptotic and neuroprotective effects of tetramethylpyrazine following spinal cord ischemia in rabbits. BMC Neurosci 2006;7:48.
35. Johnson SH, Kraimer JM, Graeber GM. Effects of flunarizine on neurological recovery and spinal cord blood flow in experimental spinal cord ischemia in rabbits. Stroke 1993;24(10):1547-53.
36. Chen S, Xiong L, Wang Q, Sang H, Zhu Z, Dong H, et al. Tetramethylpyrazine attenuates spinal cord ischemic injury due to aortic cross-clamping in rabbits. BMC Neurol 2002;2:1.
37. Xiao Z, Hu J, Lu H, Zhuo X, Xu D, Wang S, et al. Effect of tetramethylpyrazine on the expression of macrophage migration inhibitory factor in acute spinal cord injury in rats. Zhong Nan Da Xue Xue Bao Yi Xue Ban 2012;37(10):1031-6.
38. Shen ZX, Lü HB, Li XM, Xu DQ, Hu JZ, Wang XY. Tetramethylpyrazine accelerated spinal cord repair through regulation of caspase-3 and neurofilament protein expression: Tn acute spinal cord injury model in rats. Zhong Nan Da Xue Xue Bao Yi Xue Ban 2008;33(8):693-9.
39. Fan LH, Wang KZ, Cheng B, Wang CS, Dang XQ. Anti-apoptotic and neuroprotective effects of tetramethylpyrazine following spinal cord ischemia in rabbits. BMC Neurosci 2006;7:48.
40. Fiorentino DF, Zlotnik A, Vieira P, Mosmann TR, Howard M, Moore KW, et al. IL-10 acts on the antigen-presenting cell to inhibit cytokine production by Th1 cells. J Immunol 1991; 146(10):3444-51.
41. Streit WJ, Semple-Rowland SL, Hurley SD, Miller RC, Popovich PG, Stokes BT. Cytokine mRNA profiles in contused spinal cord and axotomized facial nucleus suggest a beneficial role for inflammation and gliosis. Exp Neurol 1998;152(1):74-87.
42. Matsuyama Y, Sato K, Kamiya M, Yano J, Iwata H, Isobe K. Nitric oxide: Apossible etiologic factor in spinal cord cavitation. J Spinal Disord 1998;11(3):248-52.
43. Muzio M, Salvesen GS, Dixit VM. FLICE induced apoptosis in a cell-free system. Cleavage of caspase zymogens. J Biol Chem 1997; 272(5):2952-6.
44. Bachis A, Colangelo AM, Vicini S, Doe PP, De Bernardi MA, Brooker G, et al. Interleukin-10 prevents glutamate-mediated cerebellar granule cell death by blocking caspase-3-like activity. J Neurosci 2001;21(9):3104-12.
45. Boyd ZS, Kriatchko A, Yang J, Agarwal N, Wax MB, Patil RV. Interleukin-10 receptor signaling through STAT-3 regulates the apoptosis of retinal ganglion cells in response to stress. Invest Ophthalmol Vis Sci 2003;44(12):5206-11.
46. Springer JE, Azbill RD, Knapp PE. Activation of the caspase-3 apoptotic cascade in traumatic spinal cord injury. Nat Med 1999; 5(8):943-6.
47. Citron BA, Arnold PM, Sebastian C, Qin F, Malladi S, Ameenuddin S, et al. Rapid upregulation of caspase-3 in rat spinal cord after injury: mRNA, protein, and cellular localization correlates with apoptotic cell death. Exp Neurol 2000;166(2):213-26.
48. Davies AL, Hayes KC, Dekaban GA. Clinical correlates of elevated serum concentrations of cytokines and autoantibodies in patients with spinal cord injury. Arch Phys Med Rehabil 2007; 88(11):1384-93.
49. Yang Z, Zingarelli B, Szabo C. Crucial role of endogenous interleukin- 10 production in myocardial ischemia/reperfusion injury. Circulation 2000;101(9):1019-26.
50. Sawada M, Suzumura A, Hosoya H, Marunouchi T, Nagatsu T. Interleukin-10 inhibits both production of cytokines and expression of cytokine receptors in microglia. J Neurochem 1999; 72(4):1466-71.
51. Spera PA, Ellison JA, Feuerstein GZ, Barone FC. IL-10 reduces rat brain injury following focal stroke. Neurosci Lett 1998;251(3):189-92.
52. Kopp MA, Liebscher T, Niedeggen A, Laufer S, Brommer B, Jungehulsing GJ, et al. Small-molecule-induced Rho-inhibition: NSAIDs after spinal cord injury. Cell Tissue Res 2012;349(1):119-32.
53. Rose P, Huang Q, Ong CN, Whiteman M. Broccoli and watercress suppress matrix metalloproteinase-9 activity and invasiveness of human MDA-MB-231 breast cancer cells. Toxicol Appl Pharmacol 2005;209(2):105-13.
54. Heiss E, Herhaus C, Klimo K, Bartsch H, Gerhauser C. Nuclear factor κB is a molecular target for sulforaphane-mediated antiinflammatory mechanisms. J Biol Chem 2001;276(34):32008-15.
55. Choi WY, Choi BT, Lee WH, Choi YH. Sulforaphane generates reactive oxygen species leading to mitochondrial perturbation for apoptosis in human leukemia U937 cells. Biomed Pharmacother 2008;62(9):637-44.
56. Birkedal-Hansen H, Moore WG, Bodden MK, Windsor LJ, Birkedal-Hansen B, DeCarlo A, et al. Matrix metalloproteinases: Areview. Crit Rev Oral Biol Med 1993;4(2):197-250.
57. Mott JD, Werb Z. Regulation of matrix biology by matrix metalloproteinases. Curr Opin Cell Biol 2004;16(5):558-64.
58. Lempinen M, Inkinen K, Wolff H, Ahonen J. Matrix metalloproteinases 2 and 9 in indomethacin-induced rat gastric ulcer. Eur Surg Res 2000;32(3):169-76.
59. Mori N, Sato H, Hayashibara T, Senba M, Geleziunas R, Wada A, et al. Helicobacter pylori induces matrix metalloproteinase-9 through activation of nuclear factor κB. Gastroenterology 2003; 124(4):983-92.
60. Noble LJ, Donovan F, Igarashi T, Goussev S, Werb Z. Matrix metalloproteinases limit functional recovery after spinal cord injury by modulation of early vascular events. J Neurosci 2002; 22(17):7526-35.
61. Thimmulappa RK, Mai KH, Srisuma S, Kensler TW, Yamamoto M, Biswal S. Identification of Nrf2-regulated genes induced by the chemopreventive agent sulforaphane by oligonucleotide microarray. Cancer Res 2002;62(18):5196-203.
62. Brandenburg LO, Kipp M, Lucius R, Pufe T, Wruck CJ. Sulforaphane suppresses LPS-induced inflammation in primary rat microglia. Inflamm Res 2010;59(6):443-50.
63. Fu J, Huang H, Liu J, Pi R, Chen J, Liu P. Tanshinone IIA protects cardiac myocytes against oxidative stress-triggered damage and apoptosis. Eur J Pharmacol 2007;568(1-3):213-21.
64. Zhao BL, Jiang W, Zhao Y, Hou JW, Xin WJ. Scavenging effects of Salvia miltiorrhiza on free radicals and its protection for myocardial mitochondrial membranes from ischemia-reperfusion injury. Biochem Mol Biol Int 1996;38(6):1171-82.
65. Beattie MS, Hermann GE, Rogers RC, Bresnahan JC. Cell death in models of spinal cord injury. Prog Brain Res 2002;137:37-47.
66. Lee B, Butcher GQ, Hoyt KR, Impey S, Obrietan K. Activitydependent neuroprotection and cAMP response element-binding protein (CREB): kinase coupling, stimulus intensity, and temporal regulation of CREB phosphorylation at serine 133. J Neurosci 2005;25(5):1137-48.
67. Kan S, Cheung WM, Zhou Y, Ho WS. Enhancement of doxorubicin cytotoxicity by tanshinone IIA in HepG2 human hepatoma cells. Planta Med 2014;80(1):70-6.
68. Chiu SC, Huang SY, Chen SP, Su CC, Chiu TL, Pang CY. Tanshinone IIA inhibits human prostate cancer cells growth by induction of endoplasmic reticulum stress in vitro and in vivo. Prostate Cancer Prostatic Dis 2013;16(4):315-22.
69. Chen SY, Hsiao G, Hwang HR, Cheng PY, Lee YM. Tetramethylpyrazine induces heme oxygenase-1 expression and attenuates myocardial ischemia/reperfusion injury in rats. J Biomed Sci 2006;13(5):731-40.
70. Zhu XL, Xiong LZ, Wang Q, Liu ZG, Ma X, Zhu ZH, et al. Therapeutic time window and mechanism of tetramethylpyrazine on transient focal cerebral ischemia/reperfusion injury in rats. Neurosci Lett 2009;449(1):24-7.
71. Kwan CY, Daniel CE, Chen MC. Inhibition of vasoconstriction by tetramethylpyrazine: does it act by blocking the voltage-dependent Ca2+ channel? J Cardiovasc Pharmacol 1990;15(1):157-62.
72. Zhang Z, Wei T, Hou J, Li G, Yu S, Xin W. Tetramethylpyrazine scavenges superoxide anion and decreases nitric oxide production in human polymorphonuclear leukocytes. Life Sci 2003;72(22): 2465-72.
73. Sheu JR, Kan YC, Hung WC, Ko WC, Yen MH. Mechanisms involved in the antiplatelet activity of tetramethylpyrazine in human platelets. Thromb Res 1997;88(3):259-70.